搜索筛选:
搜索耗时4.5427秒,为你在为你在102,285,761篇论文里面共找到 2 篇相符的论文内容
发布年度:
Carfilzomib and dexamethasone (Kd) vs bortezomib and dexamethasone (Vd) in patients with relapsed mu
[会议论文] 作者：Philippe Moreau,Antonio Palumbo,Douglas Joshua,Ludek Pour,Roman Hájek,Thierry Facon,Heinz Ludwig,Albert Oriol,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: ENDEAVOR (NCT01568866) is comparing Kd with Vd in patients with RMM.The primary endpoint is PFS.Secondary endpoints include OS, ORR, peripheral neuropathy (PN) rate, and safety....
Interim results from ASPIRE, a randomized, open-label,multicenter phase 3 study evaluating carfilzom
[会议论文] 作者：keith Stewart,S.vincent Rajkumar,Meletios a.Dimopoulos,Tamás Masszi,Ivan (S)pi(c)ka,Albert Oriol,Roman,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Rd is a reference treatment for patients with RMM.KRd has shown efficacy in a phase 1/2 study in RMM (Wang et al.Blood 2013;122:3122-3128).The ASPIRE study is comparing KRd with Rd in patie...
相关搜索：
